Filing Details

Accession Number:
0000856982-19-000034
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-15 18:10:43
Reporting Period:
2019-03-13
Accepted Time:
2019-03-15 18:10:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
856982 Merit Medical Systems Inc MMSI Surgical & Medical Instruments & Apparatus (3841) 870447695
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742555 Jr. Raul Parra 1600 West Merit Parkway
South Jordan 84095
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2019-03-13 180 $59.64 463 No 4 I Indirect By 401 (k) plan
Common Stock, No Par Value Acquisiton 2019-03-14 1,000 $12.06 1,000 No 4 M Direct
Common Stock, No Par Value Acquisiton 2019-03-14 1,000 $17.27 2,000 No 4 M Direct
Common Stock, No Par Value Acquisiton 2019-03-14 1,000 $16.05 3,000 No 4 M Direct
Common Stock, No Par Value Acquisiton 2019-03-14 2,000 $44.80 5,000 No 4 M Direct
Common Stock, No Par Value Disposition 2019-03-14 5,000 $60.20 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 I Indirect By 401 (k) plan
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock options (right to buy) Disposition 2019-03-14 1,000 $0.00 1,000 $12.06
Common Stock Non-qualified stock options (right to buy) Disposition 2019-03-14 1,000 $0.00 1,000 $17.27
Common Stock Non-qualified stock options (right to buy) Disposition 2019-03-14 1,000 $0.00 1,000 $16.05
Common Stock Non-qualified stock options (right to buy) Disposition 2019-03-13 2,000 $0.00 2,000 $44.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2015-10-04 2021-10-04 No 4 M Direct
1,000 2016-02-13 2022-02-13 No 4 M Direct
2,000 2017-01-28 2023-01-28 No 4 M Direct
8,000 2019-03-02 2025-03-02 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-qualified stock options (right to buy) $28.20 2018-04-14 2024-04-14 8,000 8,000 Direct
Common Stock Non-qualified stock options (right to buy) $55.73 2020-03-01 2026-03-01 30,000 30,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-04-14 8,000 8,000 Direct
2026-03-01 30,000 30,000 Direct
Footnotes
  1. The Reporting Person's sale of Merit Medical Systems, Inc.'s Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 180 shares, with the Reporting Person's purchase of 180 shares of Merit Medical Systems, Inc.'s common stock at a price of $59.64 per share on March 13, 2019. The Reporting Person paid Merit Medical Systems, Inc. $96.57, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
  2. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.20 to $60.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  3. Becomes exercisable in equal annual installments of 20% commencing 10/04/2015.
  4. Becomes exercisable in equal annual installments of 20% commencing 02/03/2016.
  5. Becomes exercisable in equal annual installments of 20% commencing 01/28/2017.
  6. Becomes exercisable in equal annual installments of 20% commencing 04/14/2018.
  7. Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.
  8. Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.